Clinical Trial Update: Effects of Exenatide on Hypothalamic Obesity [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing exenatide for hypothalamic obesity has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothalamic Obesity

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Children's Hospitals and Clinics of Minnesota | Conditions: Hypothalamic Obesity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-03-21